General
Preferred name
SITOGLUSIDE
Synonyms
¦Â-Sitosterol ¦Â-D-glucoside ()
Alexandrin ()
β-Sitosterol β-D-glucoside ()
Eleutheroside A ()
??Sitosterol ??D-glucoside ()
DAUCOSTEROL ()
Eleutheroside A, ¦Â-Sitosterol ¦Â-D-glucoside ()
AW-10 ()
EU-4906 ()
AW 10 ()
Coriandrinol ()
Daucosterin ()
Daucosterol ()
WA 184 ()
.beta.-sitosterol-glucoside ()
NSC-165962 ()
WA-184 ()
BSS-G ()
Daucosterine ()
Sitoglusido ()
Lyoniside ()
BSSG ()
Steryl Glucosides ()
?-Sitosterol-D-glucoside ()
P&D ID
PD063025
CAS
474-58-8
Tags
available
drug candidate
Drug Status
investigational
Max Phase
2.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
PRICE
109
DESCRIPTION
Daucosterol (Sitogluside) has proliferation-enhancing activity, may be involved in the IGF1-AKT pathway. Daucosterol(??-Sitosterol ??-D-glucoside) has efficient and inexpensive neuroprotectant effect, to contribute to IGF1-like activity, could be potentially developed as a medicine for ischemic stroke treatment.
DESCRIPTION
Daucosterol (Sitogluside) has proliferation-enhancing activity, may be involved in the IGF1-AKT pathway. Daucosterol(β-Sitosterol β-D-glucoside) has efficient and inexpensive neuroprotectant effect, to contribute to IGF1-like activity, could be potentially developed as a medicine for ischemic stroke treatment.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
5
Organisms
1
Compound Sets
6
ChEMBL Drugs
Drug Repurposing Hub
MedChem Express Bioactive Compound Library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
33
Molecular Weight
576.44
Hydrogen Bond Acceptors
6
Hydrogen Bond Donors
4
Rotatable Bonds
9
Ring Count
5
Aromatic Ring Count
0
cLogP
5.85
TPSA
99.38
Fraction CSP3
0.94
Chiral centers
14.0
Largest ring
6.0
QED
0.26
QED
0.26
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Target
α-glucosidase
¦Á-glucosidase
Apoptosis
Autophagy
Reactive Oxygen Species (ROS)
¦Á-amylase, ¦Á-glucosidase, DPPH radical, Wnt/¦Â-catenin
MOA
Glucokinase inhibitor
apoptosis stimulant
Pathway
Metabolism
Immunology/Inflammation
Metabolic Enzyme/Protease
NF-κB
Source data
